In one of the first studies of its kind, a team of researchers from Keck School of Medicine of USC has found that proteins ...

The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion ...

Should you take a calcium supplement? And if so, how much? Here's what to know about calcium's benefits and some warnings.

A new study from the Keck School of Medicine at USC has found that proteins linked to inflammation may play a role in bone ...

A new study published in the journal of BMC Gasteroenterology found that patients with the liver cirrhosis had higher risk of ...

To put it another way, women over the age of 45 will spend more days in hospital due to osteoporosis than they will for ...

Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs.

OsteoStrong, the global leader in osteogenic loading technology, is hosting a live webinar featuring CEO Kyle Zagrodzky and biomedical engineer Dr. John Jaquish to discuss newly published research on ...

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.